newsfilter
← Latest News
PR Newswire·

Research Solutions Announces Agreement With Fortune 500 Biopharma Company Valued at $1 Million

  • Research Solutions (NASDAQ: RSSS) secured its largest deal in company history: a $1 million enterprise agreement with a Fortune 500 biopharmaceutical company.
  • The contract expands the customer's existing Article Galaxy relationship into a full Scite enterprise deployment across all research groups.
  • The agreement provides researchers and internal tools with access to Scite's Smart Citations, scientific literature search, full API access, and additional datasets.
  • The deal followed a months-long evaluation process involving live demonstrations, technical trials, and reviews by procurement, legal, security, architecture, and AI governance teams.
  • Scite addresses limitations in general-purpose AI models by ensuring reliable access to scholarly content, preventing citation hallucinations, and distinguishing between supported, mentioned, or contested findings.
  • The platform enables the customer's internal tools to verify claim veracity, cite evidence, and retrieve licensed full-text articles within existing workflows.
  • Research Solutions notes this agreement reflects a broader pipeline demand from large R&D organizations rebuilding search tools to ground AI agents in trusted scientific evidence.
Company
Research Solutions, Inc.
Keywords
Research Solutions, Inc.